Brooks Laboratories share news, announcements and annual reports
NSE: BROOKSBSE: 533543Pharmaceuticals & BiotechnologySmall Cap
Share price at the NSE close on 30 Oct 2026. Previous close ₹63.84.
30 Oct: open ₹65.80, high ₹66.00, low ₹59.70
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹178 Cr2,450th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 13.50
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 1.45
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 12.0%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 3.2%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.06
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 54,79557.7% delivered
Brooks Laboratories results
65 filed, newest first. Page 1 of 2.
Aug 2026
13 Aug · Results
May 2026
29 May · Results
Feb 2026
6 Feb · Results
Nov 2025
14 Nov · Results
Aug 2025
13 Aug · Results
May 2025
28 May · Results
Feb 2025
13 Feb · Results
Nov 2024
9 Nov · Results
Aug 2024
14 Aug · Results
May 2024
18 May · Results
Jan 2024
31 Jan · Results
Nov 2023
9 Nov · Results
Aug 2023
10 Aug · Results
May 2023
29 May · Results
Feb 2023
14 Feb · Results
May 2022
30 May · Results
Feb 2022
14 Feb · Results
Nov 2021
12 Nov · Results
Aug 2021
14 Aug · Results
Jul 2021
2 Jul · Results
Jun 2021
30 Jun · Results
Feb 2021
11 Feb · Results
Nov 2020
12 Nov · Results
Sep 2020
15 Sep · Results
Jul 2020
31 Jul · Results
30 Jul · Results
Jun 2020
Feb 2020
15 Feb · Results
Nov 2019
13 Nov · Results
Aug 2019
14 Aug · Results
May 2019
29 May · Results
Feb 2019
14 Feb · Results
Nov 2018
14 Nov · Results
Aug 2018
14 Aug · Results
May 2018
29 May · Results
Feb 2018
14 Feb · Results
Dec 2017
14 Dec · Results
Sep 2017
14 Sep · Results
Jun 2017
May 2017
29 May · Results
Feb 2017
14 Feb · Results
Nov 2016
14 Nov · Results
Aug 2016
May 2016
Feb 2016
Nov 2015
Aug 2015
May 2015
29 May · Results